Narwhal Capital Management increases AmSurg stake by 2.6% — 3 notes

During the third quarter of fiscal year 2016, Narwhal Capital Management increased its stake in Nashville, Tenn.-based AmSurg by 2.6 percent, according to The Cerbat-Gem.

Advertisement

Here are three notes:

1. The firm had a nearly $1.1 million stake in AmSurg at the end of Q3.

2. Citigroup rated AmSurg shares a “buy” rating on Sept. 26, 2016.

3. Citigroup set a $79 price target on AmSurg shares.

More articles on surgery centers:
Ortho Montana, St. Vincent Healthcare & Yellowstone Surgery Center expand outpatient services through Montana Ambulatory Care Campus: 4 highlights
Teachers Advisors bolsters stake in AmSurg in Q3; Tenet to sell hospitals in noncore markets & more — 4 ASC company key notes
Top ASC liquidity analysis: 22 statistics on cash, accounts receivable & net working capital

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Is ambulatory care healthcare’s big margin engine? 4 leaders weigh in

Wednesday, July 29
1:00 PM - 2:00 PM CDT

Presenters: Joe Ganley, athenahealthJeffrey Flynn, CASC, Gramercy Surgery CenterBryan Tsao, Access Center, Loma Linda University HealthJason Zepeda, Northridge Hospital Medical Center, CommonSpirit HealthGreg DeConciliis, PA-C, CASC, Boston Out­Patient Surgical Suites

Advertisement

Next Up in ASC Transactions & Valuation Issues

Advertisement

Comments are closed.